En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Clinical Laboratory

Blood/Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microscopes

Pipettes

General Lab

Microplate Reader

Urine Analyzer

Ready-to-use kits for analysis

Rapid Tests

Other

Browse Products by Category

Close

QIAGEN

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including complete kits for pre-defined applications in sample preparation and analysis, and individual enzymes and reagents. It also offers instruments for automating the full range of laboratory procedures, from the initia ...
Products NewsSummary
Close

News of QIAGEN

QIAGEN to Focus on Molecular Testing amidst Coronavirus Pandemic after Voluntary Public Takeover Offer by Thermo Fisher Falls Short

14 Aug 2020
QIAGEN to Focus on Molecular Testing amidst Coronavirus Pandemic after Voluntary Public Takeover Offer by Thermo Fisher Falls Short
QIAGEN N.V. (Venlo, Netherlands) plans to continue executing its growth strategy aimed at creating significant value for shareholders and other stakeholders after the voluntary public takeover offer by Thermo Fisher Scientific Inc. (Waltham, MA, USA) failed to achieve the minimum 66.67% acceptance threshold from QIAGEN shareholders.
Read More

QIAGEN Enters into Agreement to Acquire STAT-Dx

13 Feb 2018
QIAGEN Enters into Agreement to Acquire STAT-Dx
QIAGEN N.V. has entered into an agreement to acquire STAT-Dx, a privately-held company which develops next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology and proven QIAGEN chemistries.
Read More

Qiagen Acquires Bioinformatics Firm OmicSoft

12 Jan 2017
Qiagen Acquires Bioinformatics Firm OmicSoft
QIAGEN N.V., a provider of sample and assay technologies, has acquired OmicSoft Corporation, which focuses on biomarker data management, visualization, and analysis.
Read More
Close

About QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including complete kits for pre-defined applications in sample preparation and analysis, and individual enzymes and reagents. It also offers instruments for automating the full range of laboratory procedures, from the initial sample preparation to the final test result.

Recently updated

KRAS PCR Assay
therascreen KRAS RGQ PCR Kit

The therascreen KRAS RGQ PCR Kit is an FDA-approved, qualitative real-time PCR assay for the detection of specific mutations in the KRAS oncogene. The kit provides reagents optimized for rapid and sensitive detection of seven somatic mutations using the Rotor-Gene Q MDx instrument.
More details

PCR Assay
ipsogen JAK2 RGQ PCR Kit

The ipsogen JAK2 RGQ PCR Kit is a qualitative in vitro diagnostic test for the detection of the JAK2 V617F/G1849T allele in genomic DNA extracted from EDTA whole blood. The test is a real-time PCR assay performed on the QIAGEN Rotor-Gene Q MDx (US) instrument and is intended for use as an adjunct to the evaluation of suspected myeloproliferative neoplasms (MPNs), in conjunction with other clinicopathological factors.
More details

PIK3CA Test
PIK3CA RGQ PCR Kit

The PIK3CA RGQ PCR Kit is the first FDA-approved companion diagnostic (CDx) test to identify patients with advanced breast cancer for whom treatment with the ∝-selective PI3K-inhibitor PIQRAY (alpelisib) may be appropriate. The unique molecular test is based on the detection of specific PIK3CA mutations in tumor DNA isolated from either FFPE tumor tissue or plasma samples.
More details

Clinical Laboratory

KRAS PCR Assay
therascreen KRAS RGQ PCR Kit

The therascreen KRAS RGQ PCR Kit is an FDA-approved, qualitative real-time PCR assay for the detection of specific mutations in the KRAS oncogene. The kit provides reagents optimized for rapid and sensitive detection of seven somatic mutations using the Rotor-Gene Q MDx instrument.
More details

PCR Assay
ipsogen JAK2 RGQ PCR Kit

The ipsogen JAK2 RGQ PCR Kit is a qualitative in vitro diagnostic test for the detection of the JAK2 V617F/G1849T allele in genomic DNA extracted from EDTA whole blood. The test is a real-time PCR assay performed on the QIAGEN Rotor-Gene Q MDx (US) instrument and is intended for use as an adjunct to the evaluation of suspected myeloproliferative neoplasms (MPNs), in conjunction with other clinicopathological factors.
More details

PIK3CA Test
PIK3CA RGQ PCR Kit

The PIK3CA RGQ PCR Kit is the first FDA-approved companion diagnostic (CDx) test to identify patients with advanced breast cancer for whom treatment with the ∝-selective PI3K-inhibitor PIQRAY (alpelisib) may be appropriate. The unique molecular test is based on the detection of specific PIK3CA mutations in tumor DNA isolated from either FFPE tumor tissue or plasma samples.
More details

In Vitro Diagnostic Test
QuantiFERON-TB Gold (QFT) Kit

The QuantiFERON-TB Gold (QFT) Kit is an in vitro diagnostic test that aids in the detection of M. tuberculosis infection. QFT is an interferon γ (IFNγ) release assay (IGRA) which measures the cell-mediated response to specific TB antigens in whole blood.
More details

Nucleic Acid Amplification & Detection System
Rotor-Gene Q MDx

The Rotor-Gene Q MDx enables high-precision IVD-validated real-time PCR analysis and offers outstanding thermal and optical performance due to its rotary format. Used in combination with QIAGEN’s broad portfolio of CE-IVD-marked PCR kits, it is highly suited for in vitro diagnostic applications.
More details

DNA/RNA Analysis System
QIAxcel Advanced

The QIAxcel Advanced System fully automates sensitive, high-resolution capillary electrophoresis of up to 96 samples per run and allows DNA fragment analysis of 12 samples to be performed in three minutes. It utilizes ready-to-run gel cartridges, which allow 96 samples to be analyzed with a minimum of hands-on interaction, thus reducing manual handling errors and eliminating the need for tedious gel preparation.
More details
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions